Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphoma. Munz N, Arribas AJ, Bordone Pittau R, Simonetta F, et al. Br J Haematol 2025 Oct 7. doi: 10.1111/bjh.70185.

Read + Share

Amedeo Smart

Independent Medical Education

Munz N, Arribas AJ, Bordone Pittau R, Simonetta F, et al. Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphoma. Br J Haematol 2025 Oct 7. doi: 10.1111/bjh.70185.
PMID: 41057281